-
1
The study aimed to boost HPV vaccination rates in pediatric patients.
-
2
A multicomponent intervention was tested over 36 months.
-
3
Initial vaccination rates showed no statistical significance.
-
4
Intervention group showed improved initiation rates to 82.0% at 36 months.
-
5
Clinician behaviors improved, including addressing parental hesitancy.
-
6
Implementation was disrupted by the COVID-19 pandemic.
-
7
A system-focused approach is critical for sustainable vaccination workflows.
Original Source(s)
HPV Uptake Grows Over Time
Clinical trial finds that, while multicomponent strategy did not significantly boost HPV vaccination at fixed time points, initiation rates improved steadily over time
-
by Conexiant News Staff
March 3, 2026
-
3 min
Related Content
Leukemia Case Prompts Broader Review
Researchers assess hematologic malignancies temporally associated with mRNA COVID-19 vaccination.
February 12, 2026
-
4 min
AMA Backs Structured Vaccine Review
Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.
February 11, 2026
-
4 min
When Obesity Meets Infection Risk
Researchers analyze data from Finnish cohorts and the UK Biobank to examine how body mass index relates to severe infections and their global burden.
February 10, 2026
-
4 min